EULAR® 2024 Insights: Long-Term Improvements in Serum Uric Acid Levels, Gout Symptoms, and Safety Up to 12-Months With SEL-212 in Gout Refractory to Conventional Therapy: Results From the DISSOLVE I Phase 3, Double-Blind, Placebo-Controlled Clinical Trial